Adamis Pharmaceuticals Corp

NASDAQ:ADMP   3:59:56 PM EDT
0.43
+0.02 (+5.29%)
Earnings Announcements

Adamis Pharmaceuticals Posts Q3 Revenue $4.3 Mln

Published: 11/09/2020 22:15 GMT
Adamis Pharmaceuticals Corp (ADMP) - Adamis Pharmaceuticals Announces Third Quarter 2020 Financial Results and Business Update.
Q3 Revenue $4.3 Million.
Q3 Revenue Estimate $7 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $5.8 Million
Adjusted EPS is expected to be -$0.06

Next Quarter Revenue Guidance is expected to be $7.46 Million
Next Quarter EPS Guidance is expected to be -$0.03

More details on our Analysts Page.